期刊名称：JOURNAL OF INFLAMMATION RESEARCH
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Aims and Scope
The Journal of Inflammation Research is an international, peer-reviewed, open access journal that welcomes laboratory and clinical findings on the molecular basis, cell biology and pharmacology of inflammation.
Meta-analyses will no longer be considered for publication.
Specific topics covered by the journal include:
- acute/chronic inflammation
- mediators of inflammation
- cellular processes
- molecular mechanisms
- neuroimmune mechanisms
- pharmacology and novel anti-inflammatory drugs
- clinical conditions involving inflammation
The journal welcomes original research manuscripts, reviews, symposium reports, hypothesis formation, expert opinions and commentaries relating to all aspects of inflammation.
The journal does not consider case reports except in circumstances where they make a valuable contribution to the literature. Protocols of prospective studies need to be accompanied by detailed and original video demonstrations of the proposed research.
When considering submission of a paper utilizing publicly-available data (e.g. SEER/GWAS/TCGA/GEO etc.), authors should ensure that such studies add significantly to the body of knowledge about a specific disease and that they are validated with appropriate bioinformatic analyses.
Indexed online:
- PubMed and PubMed Central (J Inflamm Res)
- Science Citation Index Expanded (also known as SciSearch®)
- Journal Citation Reports/Science Edition
- Current Contents®/Life Sciences
- Embase, from 2010 (Correct as at December 8, 2016)
- Scopus, from 2010 (Correct as at December 8, 2016)
- Directory of Open Access Journals (DOAJ)
- OAIster - The Open Access Initiative
Instructions to Authors
Manuscript preparation
- While the editors fully understand the extra challenges posed to authors whose native language is not English, we must ask that all manuscripts be reviewed and edited by a native speaker of English with expertise in that area prior to submission
- Double-spacing
- 3-cm margins
- Page numbers
- Line numbers
- Clear concise language
- American spelling (all components of a manuscript must be in English)
- Ensure tables and figures are cited
- The preferred electronic format for text is Microsoft Word
- Manuscripts will be accepted in LaTeX as long as the native LaTeX and a PDF is also supplied
- Use International Systems of Units (SI) symbols and recognized abbreviations for units of measurement
- Do not punctuate abbreviations eg, et al, ie
- Spell out acronyms in the first instance in the abstract and paper
- Word counts are not specified. In general, shorter items range from 1000 to 3000 words and reviews from 3000 to 7,500
- Generic drug names are used in title, text, tables, and figures
- Suppliers of drugs, equipment, and other brand-name material are credited in parentheses (company, name, city, state, country)
- If molecular sequences are used, provide a statement that the data have been deposited in a publicly accessible database, eg, GenBank, and indicate the database accession number
- Depositing laboratory protocols on protocols.io is encouraged, where a DOI can be assigned to the protocol. To include a link to a protocol in your manuscript:
1) Describe your step-by-step protocol on protocols.io
2) Select "Get DOI" to issue your protocol with a unique DOI (digital object identifier)
3) Include the DOI link in the Methods section of your manuscript using the format provided by protocols.io: http://dx.doi.org/10.17504/protocols.io.xxxxxxx (where xxxxxxx is the unique DOI)
At this stage, your protocol is only visible to those with the link. This allows editors and reviewers to consult your protocol when evaluating the manuscript. You can make your protocols public at any time by selecting "Publish" on the protocols.io website. Any referenced protocols will automatically be made public when your article is published.
Updated 7 January 2019
Editorial Board
Dr Quan
Department of Oral Biology, College of Dentistry, The Ohio State University, United States
Editor-in-Chief: Professor Ning Quan
Dr. Quan is a Professor at the Florida Atlantic University where he serves as a member of the Brain Institute and the Deapartment of Biomedical Science in the College of Medicine. During his PhD thesis research, he demonstrated a hypothermic effect of norepinephrine in the preoptic area of the hypothalamus. As a postdoctoral fellow at Duke University, he demonstrated the existence of IL-1 bioactivity in normal brain, linking this inflammatory cytokine to physiological neural functions of the central nervous system (CNS). During his research fellowship at the National Institute of Mental Health, He demonstrated that the blood brain barrier can serve as a relay of neuroimmune communication, transmitting peripheral immune signal to the brain.
Dr. Quan's past research at the Ohio State University focused on understanding the communication pathways between the immune system and the CNS and the neural functions of the mediators of neuroimmune communication. He demonstrated a role for proinflammatory cytokines in mediating neurodegeneration induced by the chronic CNS infection of Trypanosoma brucei, described the temporospatial distribution of IL-1 and COX-2 expression after peripheral immune challenge, uncovered a location-specific neural pathway by which localized peripheral inflammation signals brain, discovered multiple promoters in the IL-1R1 gene that drives cell type specific expression of IL-1R1 in the CNS to mediate diverse functions of IL-1 in the brain, leading to the identification of IL-1R3. His current research includes further dissecting the role of IL-1R1 and COX-2 in the brain by creating and analyzing mouse lines which express these molecules in specific cell types of the brain, elucidating mechanisms underlying a novel type of peripheral inflammation recently discovered in his lab-inflammation without the induction of sickness behaviors and neuroimmune activation, and exploring the potential clinical benefits of this type of inflammation.
At national and international levels, Dr. Quan has served as a member and chairman of multiple NIH study sections, a member of grant review panels for UK and Canada and on the editorial boards of multiple journals.
Editorial Board
Professor Amar
UNITED STATES
Salomon Amar, Provost for Biomedical Research/Chief Biomedical Research Officer, Touro College and University System; Professor of Pharmacology, Professor of Microbiology and Immunology, New York Medical College, Valhalla, NY, USA
Professor Bazan
UNITED STATES
Haydee E.P. Bazan, Professor, Department of Ophthalmology, LSU Health Science Center, LA, USA
Professor Blalock
UNITED STATES
J. Edwin Blalock, Ph.D., Professor, Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, University of Alabama at Birmingham, AL, USA
Adjunct Professor Fabio Comim, Department of Clinical Medicine, Federal University of Minas Gerais (UFMG), Belo Horizonte, Brazil.
Rupert Conrad, Head of Research, Department of Psychosomatic Medicine and Psychotherapy, Bonn University Hospital, Germany
Dr Xiaoyu Liu, Postdoctoral Fellow, Charles E. Schmidt College of Medicine and Brain Institute, Florida Atlantic University, USA.
Professor Ness
UNITED STATES
Roberta B. Ness, James W. Rockwell Professorship in Public Health, The University of Texas Health Science Center at Houston, School of Public Health, Houston, Texas, USA
Domenico Pratico, Department of Pharmacology, Temple University Health Sciences Center, PA, USA
Professor Rao
UNITED STATES
P. Srirama Rao (Sriramarao), Professor, Departments of Microbiology and Immunology, Virginia Commonwealth University, VA, USA
Professor Ruddle
UNITED STATES
Nancy H. Ruddle, Professor Emerita, Epidemiology of Microbial Diseases, Yale University School of Public Health, New Haven, CT, USA
Professor Van Goor
NETHERLANDS
Harry van Goor, Department of Surgery, Radboud University Medical Centre, The Netherlands
Professor Weisman
UNITED STATES
Gary A. Weisman, Professor, Department of Biochemistry, University of Missouri-Columbia, MO, USA
|
